Prosecution Insights
Last updated: April 19, 2026

Genmab B V

4 pending office actions

Portfolio Summary

4
Total Pending OAs
4
Final Rejections
0
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
17800740 METHODS FOR THE QUANTIFICATION OF GLYCOPROTEINS XU, XIAOYUN 1797 Final Rejection Aug 18, 2022
17745667 POLYPEPTIDE VARIANTS AND USES THEREOF DAHLE, CHUN WU 1641 Final Rejection May 16, 2022
17684238 ANTI-DEATH RECEPTOR ANTIBODIES AND METHODS OF USE THEREOF DAHLE, CHUN WU 1641 Final Rejection Mar 01, 2022
17012102 DIMERIC PROTEIN WITH TRIPLE MUTATIONS HUYNH, PHUONG N 1641 Final Rejection Sep 04, 2020

Managing Genmab B V's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month